Gilead's fibrotic disease pipeline is now entirely
Post# of 157825

Novo Nordisk collaboration dismantled. Failed to reduce liver scarring in phase 2 MASH trial by Gilead. Semaglutide didn't help...by being added to Cilofexor and Firsocostat.
I don't like that they have a need...We have a filler.

